
Ultramarin is a pioneer in AI-driven asset management, developing AI-based predictive models for global stock markets to empower investors with better decision-making. They leverage a holistic approach, processing millions of data points daily using adaptive AI models that continuously learn and adapt to market changes. Their offerings include Investment Funds & Individual Mandates, providing direct access to AI-based stock strategies; Index Solutions, allowing participation in AI-optimized stock indices via ETFs; and Ultrascope, offering AI-based stock research on over 2,000 global companies. Their approach combines the potential of Artificial Intelligence with the best practices of quantitative asset management, focusing on systematic, transparent, and data-driven investment strategies.

Ultramarin is a pioneer in AI-driven asset management, developing AI-based predictive models for global stock markets to empower investors with better decision-making. They leverage a holistic approach, processing millions of data points daily using adaptive AI models that continuously learn and adapt to market changes. Their offerings include Investment Funds & Individual Mandates, providing direct access to AI-based stock strategies; Index Solutions, allowing participation in AI-optimized stock indices via ETFs; and Ultrascope, offering AI-based stock research on over 2,000 global companies. Their approach combines the potential of Artificial Intelligence with the best practices of quantitative asset management, focusing on systematic, transparent, and data-driven investment strategies.
Sector: AI-driven asset management / fintech
Founded: 2017
Headquarters: Berlin, Germany
Employees: 40
Notable products: AI-enhanced ETFs, mutual funds, Ultrascope research API
Known investors: Acton Capital; Dr. Werner Brandt
Improving investment decision-making and portfolio construction by using AI to forecast equity markets and automate quantitative strategies.
2017
Fintech / Asset Management / Quantitative Investing
Round listed as Series A with participation from Acton Capital and investor Dr. Werner Brandt.
“Acton Capital; Dr. Werner Brandt”